Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MBNL2 antibody

MBNL2 Reactivity: Human, Mouse, Rat ELISA Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7096472
  • Target See all MBNL2 Antibodies
    MBNL2 (Muscleblind-Like 2 (MBNL2))
    Reactivity
    • 23
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human, Mouse, Rat
    Host
    • 22
    • 1
    Rabbit
    Clonality
    • 22
    • 1
    Polyclonal
    Conjugate
    • 13
    • 2
    • 2
    • 2
    • 2
    • 2
    This MBNL2 antibody is un-conjugated
    Application
    • 21
    • 14
    • 13
    • 13
    • 4
    • 1
    ELISA
    Specificity
    MBNL2 Antibody detects endogenous levels of MBNL2.
    Immunogen
    A synthesized peptide derived from human MBNL2.
    Isotype
    IgG
    Top Product
    Discover our top product MBNL2 Primary Antibody
  • Application Notes
    ELISA(peptide) 1:20000-1:40000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C. Stable for 12 months from date of receipt.
    Expiry Date
    12 months
  • Target
    MBNL2 (Muscleblind-Like 2 (MBNL2))
    Alternative Name
    MBNL2 (MBNL2 Products)
    Synonyms
    1110002M11Rik antibody, AI047808 antibody, AI837313 antibody, AI849185 antibody, AL118326 antibody, MBLL antibody, R75232 antibody, mKIAA4072 antibody, wu:fj89c04 antibody, MBLL39 antibody, PRO2032 antibody, muscleblind like splicing factor 2 antibody, muscleblind-like splicing regulator 2 antibody, muscleblind like splicing regulator 2 antibody, Mbnl2 antibody, mbnl2 antibody, MBNL2 antibody
    Gene ID
    10150
    UniProt
    Q5VZF2
You are here: